April 16 2014
Wednesday
April 17 2014
Thursday
April 18 2014
Friday
April 19 2014
Saturday
April 20 2014
Sunday

07:00-08:30 ROOM 1

COURSE 12
From depression to mania: How to treat the youth with mood disorders?
Rasim Somer Diler (TAP-USA)
ROOM 2

WORKSHOP -7:
Neuroimaging in psychiatric disorders
Samet Köse (TAP-USA)
ROOM 3

COURSE 13
Critical and effective reading techniques of scientific articles: How can statistical evaluation be inferred in articles?
Selim Kılıç (TAP), Cengiz Han Açıkel (TAP)
ROOM  4

MEET THE EXPERTS - 2
Child and adolescent psychiatry specialist hours
Treatment difficulties and coping
strategies in children and adolescents with OCD
Discussant Specialists:
Mücahit Öztürk (TAP) - Kağan Gürkan (Turkey)
Case Scenarists: Senem Başgül (Turkey), Esra Çöp (Turkey), Murat Coşkun (Turkey)
08:30-09:00 BREAKFAST
09:00-10:30 HALL A

JOINT SYMPOSIUM 5

AsCNP-CCNP-TAP
Update on biomarkers and novel drug targets in psychiatric disorders
Discussant moderators:
Xin Min Li (Canada) – Samet Köse (TAP-USA)
Novel drug targets for the treatment of depression: Is the glutamate era arriving?
Feyza Aricioglu (TAP)
Reactive aldehydes: What are their roles in neuropsychiatric disorders?
Glen Baker (CCNP)
Interaction of cytokines and the serotonin transporter: A new target for the treatment of mood disorders
Yuan-Hwa Chou (AsCNP)
Oligodendrocyte dysfunction in schizophrenia: Mechanism and target of treatment
Xin Min Li (Canada)
HALL B

SYMPOSIUM 6
An update on Alzheimer’s disease
from  theory to the clinical practice
Discussant moderators:
H. Murat Emül (TAP), Recep Tütüncü (TAP) Risk factors for Alzheimer's disease
Ömer Yacı (Turkey)
PET studies in Alzheimer's disease
Ebru Fındıklı  (Turkey)
Biomarkers in Alzheimer's disease
Burcu Göksan (Turkey)
The role of immune system in Alzheimer's disease: Where are we in terms of Alzheimeris disease vaccine?
Özlem Erden Aki (Turkey)
An update on the treatment of Alzheimer's disease  
Işın Baral Kulaksızoğlu
(Turkey)
 
HALL C  

SYMPOSIUM 7
Risk management in pediatric population
Discussant moderators:  Yankı Yazgan (Turkey) - Kağan Gürkan (Turkey)
How to reduce mania risk when prescribing antidepressants in children and adolescents
Neslihan Emiroğlu (Turkey)
The risk of suicide with SSRIs and prevention  
Fevziye Toros  (Turkey)
Delirium management and treatment in children and adolescents
İbrahim Durukan (TAP)

Management of adolescent self-mutilation
Cem Gökçen (Turkey)
10:30 -11:00 COFFEE BREAK
11:00-12:00

HALL A

SATELLITE SYMPOSIUM-2
 
Individual touch in treatment of schizophrenia and bipolar disorders
Moderator: Mesut Çetin (TAP)
Schizophrenia
Mesut Çetin (TAP)
Bipolar Disorders
Haluk Savaş (TAP)

11:30-12:30 Poster Presentations (PP153 - PP304)
12:00-13:00 LUNCH
13:00-14:30 HALL A

SYMPOSIUM 8
Treatment of schizophrenia: Quo vadis?
Discussant moderators: 
Cyril Hoschl (CNPS) - Samet Köse (TAP-USA)
Recognition and management of negative symptoms in schizophrenia: Past, present and future  Ali Saffet Gönül (TAP)
Recognition and management of cognitive symptoms in schizophrenia: Past, present, and future  Peter  Haddad (BAP)
Recognition and management of depressive  symptoms in schizophrenia: Past, present and future  
Serdar Dursun (TAP-Canada)

Recognition and management of treatment resistance in schizophrenia: Past, present, and future
Jaime Hallak (BPA)
HALL B

JOINT SYMPOSIUM 6

WPA-TAP
Focus on comorbidity: From theory to the clinical practice
Discussant moderators: Yuan-Hwa Chou (AsCNP) - Erhan Kurt (TAP)
Default mode network functional connectivity in patients with temporal lobe epilepsy and comorbid depressive and anxiety symptoms
Liubov Shmeleva (Russia)
Mild depression and normal sadness: Language diagnostic criteria
Daria Smirnova (Russia)

Psychiatric comorbidity in diabetes mellitus type I and type II and the role of personality in glycemic control
Olga Karpenko (Russia)
Course of panic disorder and comorbidity
Aleksey Pavlichenko (Moscow)
HALL C

SYMPOSIUM 9

Eating disorders: From different perspectives
Discussant moderators:  Rüstem Aşkın (Turkey), Mecit Çalışkan (Turkey)
Psychiatric aspects of obesity  
Atila Erol  (TAP)
Obesity as a psychiatric illness
Numan Konuk (TAP)
Binge eating disorder  
Alican Dalkılıç (TAP-USA)
Eating disorders in terms of endocrinological (dys)regulation
Selma Bozkurt Zincir (TAP)
14:30-15:00 COFFEE BREAK
15:00-16:00 HALL A

SATELLITE SYMPOSIUM - 3

 
A life with ADHD
Speakers:
Bengi Semerci (TAP)
Cengiz Başoğlu (TAP)
16:00-16:30 COFFEE BREAK
16:30-18:00 HALL A

DEBATE-1:
Moderator: Alican Dalkılıç (TAP-USA)
What does psychiatric genetics promise to clinicians: Are we rowing up the stream?
Dost Öngür (TAP-USA)  x Thomas G. Schulze (Germany)
18:00-18:30 COFFEE BREAK 
18:30-19:30 HALL A

DEBATE-2:

Moderator: Serdar Dursun (TAP-Canada )
Is polypharmacy needed in psychiatry?
Mesut Cetin (TAP) x Selçuk Kırlı (TAP)
HALL B

LITERATURE SESSION
Will disruptive mood dysregulation disorder reduce false diagnosis of bipolar disorder in children? Bipolar Disord. 2012 Aug;14(5):488-969
Author: Gabriella Carlson (USA)
Discussant: Rasim Somer Diler (TAP-USA)
19:30-20:00 COFFEE BREAK
20.00-22:00 HALL A

SYMPOSIUM 10
Individualized treatment in psychiatric practice
Discussant moderators:   
Ümit Yaşar (TAP), Aytekin  Sır (TAP)
Use of genomics approach in psychiatry: A focus to treatment response in depression 
Ümit Yaşar (TAP)
Gene-environment interactions in psychiatric disorders: Translation of neuroscientific developments into personalized medicine.
Timur S. Syunyakov (Russia)
Pharmacogenetics and individualized treatment: How relevant are drug blood levels?
Cem Şengül (TAP)
Resistance to treatment and individualized treatment
Tayfun Turan (TAP)
The risk of drug interactions in daily practice of patients with schizophrenia treated with antipsychotics
Filiz Karadağ (TAP)
HALL B

SYMPOSIUM 11

Highlights of DSM-5 changes in  posttraumatic stress disorder
Discussant moderators:   
Barbaros Özdemir (TAP)
Cemil Çelik (TAP)

Have intended DSM-5 changes achieved the purpose in PTSD?
Abdullah Bolu (Turkey)
Trauma and stress associated changes in
DSM-5
Süleyman Akarsu (Turkey)
The impact of DSM-5 changes in trauma related disorders on clinical practice
Taner Öznur (Turkey)
HALL C

SYMPOSIUM 12

Complementary and alternative therapies in psychiatry
Discussant moderators: 
Çiçek Hocaoğlu (Turkey) - Nahit Özmenler (Turkey)
Socio- demographic factors  and frequency In the use of complementary and alternative therapies in psychiatric patients 
Erman Bağcıoğlu (Turkey)
The reasons for complementary and alternative treatments in psychiatric patients
Hanifi Kokaçya (Turkey)
Which complementary and alternative treatment methods are used in psychiatric patients?
Mustafa Arı (Turkey)
Are complementary and alternative treatment methods beneficial and recommended in psychiatric patients?
Bülent Bahçeci (Turkey)
Vitamins in the treatment of psychiatric diseases and their mechanisms of action
Hayriye Baykan (Turkey)
ROOM 1

COURSE 14

Cognitive behavioral therapy for
anxiety disorders in children and adolescents
- Part 2

Satwant Singh (UK)
ROOM 2

COURSE 15
Sponsored by
Three  states of depression
Unipolar depression
Haluk Savaş (TAP)
Bipolar depression
Erhan Kurt (TAP)
Depression in schizophrenia
Özcan Uzun (TAP)  
ROOM 3

COURSE 16
How should scientific articles be prepared?
How to avoid the mistakes in planning, statistics, application, and writing that prevent publishing and leading to rejection of the manuscripts?
Publishing in high impact journals
Hasan Herken (TAP) - Murad Atmaca (TAP)
Selim Kılıç (TAP) - Cengiz Han Açıkel (TAP)


Turkish - English; English-Turkish simultaneous translation

WPA: World Psychiatric Association - BAP: British Association for Psychopharmacology - CINP: The International College of Neuropsychopharmacology
CCNP: Canadian College of Neuropsychopharmacology - CNPS: Czech Neuropsychopharmacological Society - AsCNP: Asian College of Neuropsychopharmacology
TAP: Turkish Assocation For Psychopharmacology - BPA: Brazilian Association of Psychiatry - CBTA: Cognitive Behavioral Therapy Association
ACBT: Association for Behavioral and Cognitive Therapies - BDTD: Cognitive Behavioral Therapy Association - IBGAID: Drug Awareness and Rational Drug Association